Shorts have covered their position, booked their profits & moved on to other plays. Stock has been cut from $8 to $4+. Can't see any reason a short seller would have much interest in THLD at these levels---shorts have other sandboxes to play in. Is that FAR TOO COMPLICATED for little rookie ? Sure sounds like it ! Its a pleasure having pikers like you getting filleted regularly in the markets---plus it brings out all kinds of asinine commentary which is a HOOT to read ! Dendreon.....that was a good one !
Hey rookie----put down the ice cream---you're tiny little brain is locking up. Was that a ..... "pr piece" ? so you're learnin' all about the markets !! why mommie will be proud of you ! someday when you grow up maybe you can play with the big boys !! keep 'em coming little rookie....your naievete is truly refreshing !
The same story continues in '14 that propelled the airline sector to major outperformance in '13.
You consistently show tour investment inexperience. Clearly you do not understand the concept behind stock shorting or even what different investment approaches use shorting. It's crystal clear since you haven't participated in stocks that have meaningful moves---up 20-30-40% in a day. especially in biotech----where short covering has dramatically moved the price of a stock. In THLD case that will not happen as the shorts betting against a meaningful rise in the stock are no longer involved. But since you do not understand any of this it falls on the deaf ears of little rookie. The same thing took place in your favorite Dendreon----where the shorts have covered in the $2-3 range with a big win at the expense of you little pikers holding it till death. What a riot !!
Also little beach ball baby---why do you think that THLD has fared so poorly in 2013 ? Who do you want to blame that on ? Why haven't the smart institutional biotech investors been loading up this year ??? Do you want to try any kind of guess ?
Give it a shot !!
And your point is ????? Do you have trouble understanding short selling ?? There is no meaningful short position in THLD at present----which will not provide any upside push if there is anything meaningful to get the stock to rise. As noted numerous times the short sellers covered (bought shares) when THLD got cut in half----or did you miss that too ??? Get in the game, little rookie !
AAL can trade in the $30-40 share range over the next year depending on what your EPS estimates are & the P/E multiple you wish to pay for those earnings. For example, a seasoned analyst like Helane Becker of Cowen (who's been following the industry for over 30 years) is looking for $3.10/share EPS in '14 on $42 bil revs & estimates include $300 mil of the $1 billion in targeted synergies from both airlines for an operating margin of 8% with added synergies in the next year. Using a reasonable P/e of 10 gets AAL to the low $30s. If business is stronger (economic pickup in '14, stable oil prices) you can elect to give it a higher multiple on higher earnings which can get AAL to the $35-40 range. To get above that level over the next year will require more aggressive assumptions but AAL certainly is positioned to provide a favorable reward-to-risk as well as beat the market averages over the next year.
Well many seasoned investment analysts are looking for AAL to trade in the $31-39 range in '14, with Deutsche Bank on
Monday recommending with a $35 target. Many of the top tier firms who recommended LCC (but not AAMRQ) have not put out a current opinion on the new AAL. My guess is that there will be additional positive follow through comments from analysts who remain quite bullish on the sector such as Morgan Stanley & others.
Whether they add or JPM sells is not really significant to me. I realize you are trying to find "good news" wherever possible & that is not a bad thing. But too much verbal diarrhea about things that don't amount to much is over the top. Clearly you may be interested in much of the early stage science but fail to remotely realize that non-scientists & investors are trying to make heads or tails out of where THLD is in the process. You constantly make it seem like they are knocking on the door of success & dismiss anybody who wonders why that is not recognized by professional biotech investors whose livelihood is based on analyzing the investment implications of new technology---though unproven---in THLD's portfolio.
Get off your high holy horse----if that is anyway possible---and recognize that even though you may be more understanding of ALL THINGS THLD that they don't score many points in the real world of investing. It may be sad to say that such a lack of humility may be why you are such a mean distasteful person who likely has major problems with other's investment success.
Please come down off your high holy horse for once.....pretty please ? We all recognize that you have anointed yourself as the keeper of THLD commentary but its pretty obvious that you sure don't have all of the answers---not by a long shot. Loosen up your shorts a bit & try to relax.
oh yeah I forgot.....IDIX has got GILD right where they want them !!!! Wake up & smell the coffee please !
He made a bet on IDIX & has been clobbered---can't win them all. GILD has been the play there---hook line & sinker----which hopefully you know following HCV for 20 years (??). Go play in another sandbox----THRX has sailed without you.
WOW ! Did you just come up with this ???? Do you think you are the first one to handicap this ? "Logic" ???? Based on "common sense" ? That's why small people get blasted as they take things at face value & act in the moment. Major players have been handicapping both the equity & debt scenarios for quite some time.
Tremendous----YOU are so much smarter than the markets ! I like that !!! So everyone should just follow you the pied piper ??? You think this is a game ?? HILARIOUS !
Klarman is an eclectic investor & looks for value in a variety of sectors. How do you categorize "low downside risk " ? Could it be that GSK owns 1/3 of the company & has put an additional $200,000,000 into THRX shares in 2013 ? Do some due diligence before you choose whether to participate.
Oh that must be why we're seeing all the large positions being taken in front of ASH. Will THLD bother to have posters ??? Little rook please enlighten us----we rely on you to keep all of us aware of news worthy items out of these big important scientific conferences.
You are lost in space. This acquisition is not relevant to THLD. Also, their Merck Serono biz hasn't been a poor performer with multiple setbacks that has been pointed out specifically to you little rookie. Deep pockets ??? what does that mean ???? NDAs for THLD ??? The reality is that MKGAY is shuffling the deck big time in their new management attempts to change the situation at the company-----or have you somehow missed the PR announcements ??? How could that possibly be little rook ??? Are you.....dropping the ball on all things THLD related ???? oh no........!!!!